CACA guidelines for holistic integrative management of urothelial carcinoma

Author:

Chen Xusheng,Wahafu Wasilijiang,Shen Yijun,Fan Jinhai,Yao Xin

Abstract

AbstractBladder urothelial carcinoma (UC) is the most common malignant tumor of the urinary system. It has the characteristics of high recurrence rate and poor prognosis. It is a malignant disease that threatens the safety of human life. The incidence rate has gradually increased in recent years. UC has the following characteristics: non-specific clinical symptoms, difficult preoperative qualitative diagnosis, unsatisfactory clinical treatment effect and poor prognosis. Therefore, a clear diagnosis plays a decisive role in the selection and formulation of surgical plans, and reasonable treatment is the key to improving the prognosis of patients and increasing their long-term survival rate. Based on the research evidence of diagnosis, evaluation, and treatment and the clinical experience of experts, the Cancer Nutrition Professional Committee of the Chinese Anti-Cancer Association formulated the "Guidelines for the Diagnosis and Treatment of Bladder Urothelial Carcinoma" for the reference of clinicians. It is hoped that this guideline can provide clinicians with the best and effective reference for clinical diagnosis and treatment, so as to achieve the best therapeutic effect for patients with UC in our country.

Funder

Beijing-Tianjin-Hebei Basic Research Cooperation Project

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3